Kidswell Bio Corporation [4584.T]
TOKYO, May 01 (Pulse News Wire) – Kidswell Bio Corporation (4584.T) disclosed the exercise status of its fourth series of convertible bonds and warrant issuance for April 2026. In April, no shares were delivered against the convertible bonds, resulting in a total exercise amount of ¥0.
As of the end of March, the remaining unexercised balance was ¥125 million, which decreased to ¥125 million by the end of April. There were no significant changes in the exercise status during the month.
Regarding the 23rd series of warrants, no warrants were exercised in April, leaving 13,746 outstanding warrants (equivalent to 1,374,600 shares) at the end of March, which remained unchanged at 13,746 by the end of April. All exercise limitations based on the Tokyo Stock Exchange's listing regulations and the Securities Association’s rules were adhered to throughout the month.
No additional material events occurred related to the exercise of either the convertible bonds or the warrants during the reporting period.
🟡 Confidence: Standard AI-translated content.